oral medications may be better than insulin for DM II
Long-term followup from a large cohort study confirms that in type 2 diabetes, a glycemic control strategy with insulin sensitizing reduces the incidence of diabetic peripheral neuropathy, while also improving cardiovascular outcomes. Among type 2 diabetes patients followed for up to 4 years, a glycemic control regimen…
